AETHLON MEDICAL, INC. Cash and Restricted Cash
AETHLON MEDICAL, INC. (AEMD) had Cash and Restricted Cash of $5.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.03M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.13M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.06M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.95M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $5.03M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.13M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $7.06M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $5.95M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.86M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $5.60M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $4.91M 10-Q · filed 2026-02-12 | |
| 2024-09-30 | $6.95M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $9.16M 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $5.53M 10-K · filed 2026-06-10 | |
| 2023-12-31 | $8.06M 10-Q · filed 2025-02-12 | |
| 2023-09-30 | $10.26M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $12.99M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $14.62M 10-K · filed 2025-06-26 | |
| 2022-12-31 | $17.59M 10-Q · filed 2024-02-14 | |
| 2022-09-30 | $19.69M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $15.01M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $17.16M 10-K · filed 2024-06-27 | |
| 2021-12-31 | $20.48M 10-Q · filed 2023-02-13 | |
| 2021-09-30 | $23.27M 10-Q · filed 2022-11-14 | $23.22M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $25.22M 10-Q · filed 2022-08-09 | $25.17M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $9.91M 10-K · filed 2023-06-28 | |
| 2020-12-31 | $12.18M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $14.47M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $15.72M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $9.60M 10-K · filed 2022-06-28 | |
| 2019-12-31 | $4.06M 10-Q · filed 2021-02-10 | |
| 2019-03-31 | $3.83M 10-Q · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |